MiR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4

Biochemical and Biophysical Research Communications

Volumn 435, Issue 4, 2013, Pages 745-750

  Chen, Liang ^a,b   Tang, Yanping ^a   Wang, Jian ^b   Yan, Zhongjie ^a   Xu, Ruxiang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

Apoptosis resistance; FOXO4; MiR 421; Nasopharyngeal carcinoma; Proliferation

Indexed keywords

BIM PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; MICRORNA; P21 ACTIVATED KINASE; PROTEIN P27; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXO4; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; DOWN REGULATION; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84878987577     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.056     Document Type: Article

References (26)

1. Pan Y., Claret F.X. Targeting Jab1/CSN5 in nasopharyngeal carcinoma. Cancer Lett. 2012, 326:155-160.
2. Fang W., Li X., Jiang Q., et al. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J. Transl. Med. 2008, 6:32.
3. Gao W., Li J.Z., Ho W.K., et al. Biomarkers for use in monitoring responses of nasopharyngeal carcinoma cells to ionizing radiation. Sensors (Basel). 2012, 12:8832-8846.
4. Katoh M., Igarashi M., Fukuda H., et al. Cancer genetics and genomics of human FOX family genes. Cancer Lett. 2013, 328:198-206.
5. Huang H., Tindall D.J. Dynamic FoxO transcription factors. J. Cell Sci. 2007, 120:2479-2487.
6. Kops G.J., Medema R.H., Glassford J., et al. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol. Cell Biol. 2002, 22:2025-2036.
7. Medema R.H., Kops G.J., Bos J.L., et al. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000, 404:782-787.
8. Schmidt M., Fernandez de Mattos S., van der Horst A., et al. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol. Cell Biol. 2002, 22:7842-7852.
9. Dijkers P.F., Medema R.H., Lammers J.W., et al. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr. Biol. 2000, 10:1201-1204.
10. Yang J.Y., Xia W., Hu M.C. Ionizing radiation activates expression of FOXO3a, Fas ligand, and Bim, and induces cell apoptosis. Int. J. Oncol. 2006, 29:643-648.
11. Modur V., Nagarajan R., Evers B.M., et al. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J. Biol. Chem. 2002, 277:47928-47937.
12. Kim S.H., Miller F.R., Tait L., et al. Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: biomarkers of progression. Int. J. Cancer 2009, 124:2813-2828.
13. Lee M.J., Yu G.R., Yoo H.J., et al. ANXA8 down-regulation by EGF-FOXO4 signaling is involved in cell scattering and tumor metastasis of cholangiocarcinoma. Gastroenterology 2009, 137:1138-1150.
14. Kwon I.K., Wang R., Thangaraju M., et al. PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4. Oncogene 2010, 29:3423-3434.
15. So C.W., Cleary M.L. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function. Mol. Cell Biol. 2002, 22:6542-6552.
16. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
17. William C.S. MicroRNAs in cancer - from research to therapy. Biochim. Biophys. Acta 1805, 2010:209-217.
18. Katoh M., Katoh M. Human FOX gene family (Review). Int. J. Oncol. 2004, 25:1495-1500.
19. Huang H., Tindall D.J. FOXO factors: a matter of life and death. Future Oncol. 2006, 2:83-89.
20. Borkhardt A., Repp R., Haas O.A., et al. Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23). Oncogene 1997, 14:195-202.
21. Lee E.J., Kim J.M., Lee M.K., et al. Splice variants of the forkhead box protein AFX exhibit dominant negative activity and inhibit AFXalpha-mediated tumor cell apoptosis. PLoS ONE 2008, 3:e2743.
22. Oteiza A., Mechti N. The human T-cell leukemia virus type 1 oncoprotein tax controls forkhead box O4 activity through degradation by the proteasome. J. Virol. 2011, 85:6480-6491.
23. Jiang Z., Guo J., Xiao B., et al. Increased expression of miR-421 in human gastric carcinoma and its clinical association. J. Gastroenterol. 2010, 45:17-23.
24. Hao J., Zhang S., Zhou Y., et al. MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem. Biophys. Res. Commun. 2011, 406:552-557.
25. Zhang Y., Gong W., Dai S., et al. Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells. Mol. Cancer Res. 2012, 10:516-522.
26. Zhong X.Y., Yu J.H., Zhang W.G., et al. MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene 2012, 493:44-51.